[{"Assets_0_Q2_USD":158853213.0,"CommonStockSharesOutstanding_0_Q2_shares":77633816.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31946981.0,"NetIncomeLoss_1_Q2_USD":-9479116.0,"NetIncomeLoss_2_Q2_USD":-32565023.0,"StockholdersEquity_0_Q2_USD":123433348.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]